Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05053087 · ClinicalTrials.gov registry record · Phase 3
A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
NCT05053087: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT05053087 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05053087, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this research is to study how well the adductor canal pain catheters works after a total knee arthroplasty or replacement of the knee joint. The catheter works by using either an intermittent bolus injection to provide a large dose of medication or continuous infusion of pain medicine, ropivacaine 0.2%, compared to a single-shot adductor canal block.
Interventions
- DRUG Placebo
- DRUG Ropivacaine Continuous Infusion
- DRUG Ropivacaine Intermittent Bolus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-04-13 |
| Est. Completion | 2023-02-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05053087
The ClinicalTrials.gov registry entry for NCT05053087 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05053087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05053087 about?
NCT05053087 is a clinical study titled "A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty". The purpose of this research is to study how well the adductor canal pain catheters works after a total knee arthroplasty or replacement of the knee joint. The catheter works by using either an intermittent bolus injection to provide a large dose of medication or continuous infusion of pain medicine...
What is the current status of trial NCT05053087?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2022-04-13. Estimated completion is 2023-02-27.
What interventions are being tested in trial NCT05053087?
The interventions under investigation include: Placebo (DRUG), Ropivacaine Continuous Infusion (DRUG), Ropivacaine Intermittent Bolus (DRUG).
Who is sponsoring clinical trial NCT05053087?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.